Bullishcharts

$AMRN Bullish volume in Amarin Corp pre earnings.

ロング
NASDAQ:AMRN   Amarin Corporation plc
Entry level $17.50 = Target price $20 = Stop loss $16.75
High short interest of 14.45%
Stock is well below its average analyst price target @$29.11.& buy rating.

Company profile
Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

免責事項

これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。